Mirum Pharmaceuticals Inc (MIRM)
25.72
+0.61
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Price to Book Value: 4.862 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 4.862 |
| April 30, 2024 | 4.746 |
| April 29, 2024 | 4.739 |
| April 26, 2024 | 4.623 |
| April 25, 2024 | 4.629 |
| April 24, 2024 | 4.540 |
| April 23, 2024 | 4.616 |
| April 22, 2024 | 4.569 |
| April 19, 2024 | 4.500 |
| April 18, 2024 | 4.455 |
| April 17, 2024 | 4.508 |
| April 16, 2024 | 4.538 |
| April 15, 2024 | 4.519 |
| April 12, 2024 | 4.646 |
| April 11, 2024 | 4.882 |
| April 10, 2024 | 4.845 |
| April 09, 2024 | 4.952 |
| April 08, 2024 | 4.899 |
| April 05, 2024 | 4.964 |
| April 04, 2024 | 4.788 |
| April 03, 2024 | 4.676 |
| April 02, 2024 | 4.765 |
| April 01, 2024 | 4.810 |
| March 28, 2024 | 4.748 |
| March 27, 2024 | 4.748 |
| Date | Value |
|---|---|
| March 26, 2024 | 4.710 |
| March 25, 2024 | 4.941 |
| March 22, 2024 | 4.939 |
| March 21, 2024 | 4.922 |
| March 20, 2024 | 5.102 |
| March 19, 2024 | 5.105 |
| March 18, 2024 | 4.911 |
| March 15, 2024 | 5.06 |
| March 14, 2024 | 5.325 |
| March 13, 2024 | 5.249 |
| March 12, 2024 | 5.194 |
| March 11, 2024 | 5.092 |
| March 08, 2024 | 5.321 |
| March 07, 2024 | 5.300 |
| March 06, 2024 | 5.338 |
| March 05, 2024 | 5.261 |
| March 04, 2024 | 5.389 |
| March 01, 2024 | 5.500 |
| February 29, 2024 | 5.394 |
| February 28, 2024 | 5.428 |
| February 27, 2024 | 5.564 |
| February 26, 2024 | 5.460 |
| February 23, 2024 | 5.225 |
| February 22, 2024 | 5.302 |
| February 21, 2024 | 5.316 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.076
Minimum
Nov 20 2019
19.35
Maximum
Sep 15 2023
5.473
Average
4.946
Median
Jul 15 2021
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.68 |
| Vanda Pharmaceuticals Inc | 0.5037 |
| Sarepta Therapeutics Inc | 14.28 |
| Puma Biotechnology Inc | 4.452 |
| Reneo Pharmaceuticals Inc | 0.6487 |
Price to Book Value Related Metrics
| PS Ratio | 5.641 |
| PEG Ratio | -69.60 |
| Price | 25.72 |
| Earnings Yield | -15.63% |
| Market Cap | 1.209B |
| PEGY Ratio | -69.60 |